Additionally, it improves cardiovascular health and has anti-diabetic properties
Medical weight loss through injections is intended to support a healthy lifestyle and cannot be separated from diet, exercise, and medical supervision
supporting numerous aspects of health including: normal detoxification, immune health, joint and cartilage health, cardiovascular health, and brain health
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
People on semaglutide typically lose 1015% of body weight over 6 months when combined with modest dietary changes and movement, though individual results vary widely
All three of these affect weight